Conveners
Collaborating with Industry - the perils and the pleasure
- Emma Liepa (Australian Synchrotron)
-
Dr John Cullen (Aspen Australia)26/11/2015, 11:00Biological SystemsOralWhile synchrotron science is well beyond most clinicians, our research suggests it will become an important tool in future clinical research. Although there is a lot of science behind the clinical and pharmacological understanding of drug products formulation, what actually happens inside the tablet before and during the administration process is mostly empirical and sometimes...Go to contribution page
-
Prof. Barry Noller (The University of Queensland)26/11/2015, 11:30Earth and EnvironmentOralIndustry engagement offers alternative sources of applied research funding. Because industry and the private sector are culturally-different to both government and the tertiary sector, the challenge is to sell the need for the high investment cost of applied research to deliver the outcome needed by industry within a prescribed framework and time limit. Academic freedom is constrained in the...Go to contribution page
-
Dr Buzz Palmer (STC Australia)26/11/2015, 11:50OralAustralia ranks third in the world with respect to excellence in academic research, indicating that Australia is exceptionally pioneering and cutting edge. Many Australian universities rank highly globally for innovation and STEMM, there is an exciting, attainable opportunity to position universities locally, regionally, nationally and internationally as entrepreneurial ecosystem foundations....Go to contribution page
-
26/11/2015, 12:10